Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Safety, xiii

R. C. Santon, Explosion Hazards at CHP and CCGT Plants, Hazards XIII Process Safety—The Future, Symposium Series No. 141, Institution of Chemical Engineers, Rugby, UK, 1997. [Pg.76]

Friction Sensitivity, It is a measure of the resistance of an expl to friction, one of the properties required for determining safety in handling and transportation. Several methods for its determination are briefly described in Vol 1, p XIII... [Pg.309]

When one compares the risk of caffeine as taken in one cup of coffee to that from the forest herbicide, 2,4-D, one finds that the margin of safety for teratogenesis or birth defects ranges from 5 to 16 (Table XIII). [Pg.347]

Giss HE. Foreword. In CE Grahm (ed) Preclinical Safety of Biotechnology Products Intended for Human Use Clinical and Biological Research, Vol. 235, Alan R. Liss, New York, 1987, pp xiii-xv. [Pg.63]

As the basis for decisions about the first dosing in humans, the preclinical safety program needs to mimic the intended clinical regimen. Although these studies are commonly conducted in normal healthy animals, they may also require development and use of an animal model that mimics the health status or condition if it is deemed to possibly sensitize the subject to treatment. For example, we have conducted studies evaluating the safety of recombinant human Factor XIII in an animal model of extracorporeal blood circulation [6] and the safety of recombinant human thrombin in an animal model of hepatic resection [7]. [Pg.973]

Ponce R, Armstrong K, Andrews K, Hensler J, Waggie K, Heffernan J, Reynolds T, Rogge M. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation. Toxicol Pathol 2005 33(6) 702-10. [Pg.983]

Ponce RA, Visich JE, Heffernan JK, Lewis KB, Pederson S, Lebel E, Andrews-Jones L, Elliott G, Palmer TE, Rogge MC. Preclinical safety and pharmacokinetics of recombinant human factor XIII. Toxicol Pathol 2005 33(4) 495-506. [Pg.983]

Rodgman, A. The V-iritrosamines in tobacco and tobacco smoke October, 1993 pp. i-xv, 1-259, see www.ijrtdocs.com 509752851 -3134, 522101837 -2121. Rodgman, A. The chemical composition of enviroirmen-tal tobacco smoke Some comments on the Occupational Safety and Health Administration s notice on Indoor Air Quality Document submitted to the Occupational Safety and Health Administration, 5 August, 1994, pp. i-xiii -I-1-172, see www.rjrtdocs.com. 515923456 -3645, 515926646 -6833, 517582702 -2904, 521186677 -6881, 521187802-7991. [Pg.1391]

Fatty acids have lethal effects on a variety of organisms (Table XIII). Ihis wide spectrvin of activity against so many pests and its safety to hunans highly reoammend the further apcdication of natural and nthetic lipids as potential insecticides. [Pg.235]

Safety auditing, as we will develop it in this work, is a structured and detailed approach to reducing and controlling the seriousness of accidents. And, safety auditing is a method whereby management can receive a continuing evaluation of its safety effectiveness [p. xiii]. [Pg.403]

The nature of the book, xi Inspiration, acknowledgements and thanks, xiii SECTION ONE The Evolution of Patient Safety Chapter 1 Medical harm a brief history, 3 Chapter 2 The emergence of patient safety, 14 Chapter 3 Integrating safety and quality, 31 SECTION TWO The Hazards of Healthcare Chapter 4 The nature and scale of error and harm, 49 Chapter 5 Reporting and learning systems, 75 Chapter 6 Measuring safety, 96... [Pg.425]

The fuel cycle data important to cost calculations are given in Table XIII. The refueling scheme is based on a six-month refueling cycle at 80% load factor. Note that the six-month refueling cycle is a limit imposed by safety criterion 6. [Pg.100]

If any deficiency in paragraphs (d)(1)(i) through (xiii) of this section (or in additional inspection items required to be checked for specific types of equipment in accordance with other sections of this standard) is identified, an immediate determination must be made by the competent person as to whether the deficiency constitutes a safety hazard. If the deficiency is determined to constitute a safety hazard, the equipment must be taken out of service until it has been corrected. See 1926.1417. [Pg.1246]

Recalling that the Commission in its PC-XIII/18, paragraph 7.2, considered and adopted the Draft OPCW Health and Safety Regulations annexed to PC-XIII/BAVP.2,... [Pg.220]

Adopts the OPCW Health and Safety Policy and the OPCW Health and Safety Regulations and takes note of the understanding recorded in paragraph 3.2 of PC-XIII/B/WP.2 annexed hereto. [Pg.295]


See other pages where Safety, xiii is mentioned: [Pg.684]    [Pg.974]    [Pg.1389]    [Pg.355]    [Pg.112]    [Pg.83]    [Pg.1357]    [Pg.353]    [Pg.115]    [Pg.337]    [Pg.220]    [Pg.295]    [Pg.55]   


SEARCH



Patient Safety Indicator XIII

© 2024 chempedia.info